JPS565414A - Chrome acetylacetonate as nutrition strengthener and medicine - Google Patents

Chrome acetylacetonate as nutrition strengthener and medicine

Info

Publication number
JPS565414A
JPS565414A JP3569380A JP3569380A JPS565414A JP S565414 A JPS565414 A JP S565414A JP 3569380 A JP3569380 A JP 3569380A JP 3569380 A JP3569380 A JP 3569380A JP S565414 A JPS565414 A JP S565414A
Authority
JP
Japan
Prior art keywords
acetylacetonate
strengthener
chrome
nutrition
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3569380A
Other languages
English (en)
Inventor
Patoritsuku Rairii Denisu
Moogan Andaason Maaku
Toruuman Rotoratsuku Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPS565414A publication Critical patent/JPS565414A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/92—Ketonic chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
JP3569380A 1979-03-19 1980-03-19 Chrome acetylacetonate as nutrition strengthener and medicine Pending JPS565414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2138279A 1979-03-19 1979-03-19

Publications (1)

Publication Number Publication Date
JPS565414A true JPS565414A (en) 1981-01-20

Family

ID=21803870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3569380A Pending JPS565414A (en) 1979-03-19 1980-03-19 Chrome acetylacetonate as nutrition strengthener and medicine

Country Status (10)

Country Link
US (1) US4571391A (ja)
EP (1) EP0016496B1 (ja)
JP (1) JPS565414A (ja)
AT (1) ATE5049T1 (ja)
AU (1) AU536196B2 (ja)
CA (1) CA1154672A (ja)
DE (1) DE3065342D1 (ja)
IE (1) IE49650B1 (ja)
NZ (1) NZ193164A (ja)
ZA (1) ZA801555B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
JP2014506932A (ja) * 2011-03-01 2014-03-20 ジェーディーエス セラピューティックス、エルエルシー 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6831881A (en) * 1980-03-31 1981-10-08 Procter & Gamble Company, The Chromium complexes as dietary supplements and pharmaceutical agents
DE3334516A1 (de) * 1983-09-23 1985-04-11 Siemens AG, 1000 Berlin und 8000 München Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen
ES2053497T3 (es) * 1986-10-27 1994-08-01 Abbott Lab Formulas nutritivas liquidas para la intolerancia a la glucosa.
IL95220A0 (en) * 1989-07-28 1991-06-10 Thymax Corp Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
US5631284A (en) * 1993-10-06 1997-05-20 University Of British Columbia Compositions and methods for relaxing smooth muscles
US5811463A (en) * 1993-10-06 1998-09-22 University Of British Columbia Compositions and method for relaxing smooth muscles
WO2003090671A2 (en) * 2002-04-23 2003-11-06 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US20060029642A1 (en) 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US9585898B2 (en) 2008-02-11 2017-03-07 Kenneth O. Russell Method for the reduction of dangerous blood sugar levels
US8932372B2 (en) 2010-02-02 2015-01-13 Celanese International Corporation Integrated process for producing alcohols from a mixed acid feed
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134797A (en) * 1960-06-13 1964-05-26 Diamond Alkali Co Preparation of chromium complexes of beta-diketones
US3914410A (en) * 1972-06-13 1975-10-21 Bristol Myers Co Method for preparing sucrose composition containing chromium III salt
US3925433A (en) * 1973-09-10 1975-12-09 Zinpro Corp 1:1 And 2:1 chromium, alpha amino acid complex salts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
JP2014506932A (ja) * 2011-03-01 2014-03-20 ジェーディーエス セラピューティックス、エルエルシー 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物

Also Published As

Publication number Publication date
NZ193164A (en) 1984-12-14
US4571391A (en) 1986-02-18
IE800547L (en) 1980-09-19
ZA801555B (en) 1981-04-29
ATE5049T1 (de) 1983-11-15
EP0016496A1 (en) 1980-10-01
CA1154672A (en) 1983-10-04
AU5650280A (en) 1980-09-25
AU536196B2 (en) 1984-04-19
IE49650B1 (en) 1985-11-13
EP0016496B1 (en) 1983-10-19
DE3065342D1 (en) 1983-11-24

Similar Documents

Publication Publication Date Title
AU536196B2 (en) Chromium acetylacetonate dietary and pharmaceutical agent
IL82209A0 (en) Insulin preparation
DE3687501D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
CA2029865A1 (en) Continuous/bolus infusor
ZA894742B (en) Mini-proinsulin,its preparation and use
ES294254U (es) Conjunto de placa de derivacion multiagujas para uso mesoterapico con custodia salvapuntas
CA2196174A1 (en) Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes
DE3783206D1 (de) Fluessige naehrwert-tabelle fuer glukose-intoleranz.
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
EP0037144A3 (en) Chromium complexes as dietary supplements and pharmaceutical agents
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
EP0267293A4 (en) PRE-TREATMENT ACTIVE INGREDIENT FOR PERCUTANEOUS ADMINISTRATION.
IL100400A0 (en) Short peptides with insulin activity
GB8818116D0 (en) Compounds & compositions for medical treatment
USD236891S (en) Best available copy
FR2390165A1 (fr) Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant
Gilioli Neuro-and psychotropic effects of industrial chemicals and performance-affecting drugs (human studies). A review of papers presented at the Workshop of PC-IAOH Sub-Committee on Higher Nervous Functions, Prague, July 1975
Anialdi et al. Drug Toxicity and the Cardiovascular System in Paediatric Patients.
DE68901114D1 (de) Tpa enthaltende arzneimittel.
IL94241A0 (en) Diagnosis and treatment of insulin dependent diabetes mellitus